Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
This dual action appears to produce greater weight loss effects, though it may also come with different side effect patterns
DPP-4 inhibitors raise incretin levels to normal or slightly above normal levels
What to track Symptoms log: Hot flash frequency and severity Sleep quality (hours, quality 1-10) Energy levels daily Mood and anxiety Brain fog incidents Period timing (if still menstruating) Body composition: Weight weekly (understanding fluctuations normal) Body measurements (waist, hips) Photos every 2-4 weeks How clothes fit Muscle vs fat changes Hormone-related: Menstrual cycle length and flow PMS symptoms Breast tenderness Libido changes Vaginal dryness Quality of life: Exercise performance Work productivity Relationship satisfaction Social engagement Overall well-being Bloodwork for perimenopause peptides Baseline testing: Estradiol (estrogen) Progesterone Testosterone (total and free) FSH (follicle-stimulating hormone - elevated in perimenopause) Thyroid panel (TSH, Free T3, Free T4) IGF-1 (growth hormone marker) Fasting glucose and insulin Lipid panel Follow-up (every 3-6 months): IGF-1 (should increase with GH peptides) Thyroid panel Fasting glucose Hormones if on HRT Adjusting based on results: Low IGF-1 still
The agency can also decline to follow the committee
Ozempic and Wegovy are FDA-approved finished drugs that are trademarks of their respective owner
US$ 26.81
US$ 27.12
US$ 21.39
US$ 28.64
US$ 25.21
